As risk drops, so do the restrictions. In the low-risk phase, for example, gatherings are still limited, but to 20 people rather than 10. An earlier draft of the plan, published Friday on the city of ...
Alumis Inc. has announced the successful completion of patient enrollment in its pivotal Phase 3 ONWARD clinical program for ESK-001, a treatment for moderate-to-severe plaque psoriasis, involving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback